申请人:——
公开号:US20030078267A1
公开(公告)日:2003-04-24
1
The invention provides a process for preparing a compound of formula (I) and pharmaceutically acceptable derivatives thereof in which: R
0
is halogen, C
1-6
alkyl, C
1-6
alkoxy, C
1-6
alkoxy substituted by one or more fluorine atoms, or O(CH
2
)
n
NR
4
R
5
; R
1
and R
2
are independently selected from H, C
1-6
alkyl, C
1-6
alkyl substituted by one or more fluorine atoms, C
1-6
alkoxy C
1-6
hydroxyalkyl, SC
1-6
alkyl, C(O)H, C(O)C
1-6
alkyl, C
1-6
alkylsulphonyl, C
1-6
alkoxy substituted by one or more fluorine atoms, O(CH
2
)
n
CO
2
C
1-6
alkyl, O(CH
2n
SC
1-6
alkyl, (CH
2
)
n
NR
4
R
5
, (CH
2
)
n
SC
1-6
alkyl or C(O)NR
4
R
5
; with the proviso that when R
0
is at the 4-position and is halogen, at least one of R
1
and R
2
is C
1-6
alkylsulphonyl, C
1-6
alkoxy substituted by one or more fluorine atoms, O(CH
2
)
n
CO
2
C
1-6
alkyl, O(CH
2
)
n
SC
1-6
alkyl, (CH
2
)
n
NR
4
R
5
or (CH
2
)
n
SC
1-6
alkyl, C(O)NR
4
R
5
; R
3
is C
1-6
alkyl or NH
2
; R
4
and R
5
are independently selected from H, or C
1-6
alkyl or, together with the nitrogen atom to which they are attached, form a 4-8 membered saturated ring; and n is 1-4; which comprises oxidizing a corresponding compound of formula (II) or an isomer thereof.
本发明提供了一种制备式(I)化合物及其药学可接受衍生物的方法,其中:R0为卤素,C1-6烷基,C1-6烷氧基,C1-6烷氧基被一个或多个氟原子取代,或O(CH2)nNR4R5; R1和R2分别选自H,C1-6烷基,C1-6烷基被一个或多个氟原子取代,C1-6烷氧基,C1-6羟基烷基,SC1-6烷基,C(O)H,C(O)C1-6烷基,C1-6烷基磺酰基,C1-6烷氧基被一个或多个氟原子取代,O(CH2)nCO2C1-6烷基,O(CH2nSC1-6烷基,(CH2)nNR4R5,(CH2)nSC1-6烷基或C(O)NR4R5; 前提是当R0位于4位且为卤素时,R1和R2中至少有一个为C1-6烷基磺酰基,C1-6烷氧基被一个或多个氟原子取代,O(CH2)nCO2C1-6烷基,O(CH2)nSC1-6烷基,(CH2)nNR4R5或(CH2)nSC1-6烷基,C(O)NR4R5; R3为C1-6烷基或NH2; R4和R5分别选自H或C1-6烷基,或与它们连接的氮原子一起形成4-8成员饱和环; n为1-4;其中包括氧化式(II)化合物或其异构体的相应化合物。